• Roche has launched two new, real-time PCR tests to detect cyclospora, a diarrhea-causing infection, to help meet diverse needs of laboratories.
  • The new tests expand the Roche cyclospora portfolio, providing laboratories with more flexible choices.
  • Cyclospora tests are another example of Roche's leadership in infectious disease testing and long-standing commitment to improving public health.

INDIANAPOLIS, Aug. 6, 2026 /PRNewswire/ -- As a cyclospora outbreak continues to spread throughout the United States,1,2 Roche ((SIX: RO, ROG, OTCQX:RHHBY), in collaboration with subsidiary TIB MOLBIOL, announces the availability of two new flexible and cost-effective research PCR testing options for labs to address the public health impact of the Cyclospora cayetanensis parasite.